Dr. Ronald Laracuente, MD

Dr. Laracuente practices at Ronald Laracuente MD PA in Boca Raton, Florida.

Dr. Laracuente's NPI, 1043260391, was assigned on May 10, 2006. Dr. Laracuente graduated from Rutgers New Jersey Medical School in 1996. Dr. Laracuente holds Florida license ME80924.

Dr. Laracuente's primary practice is Ronald Laracuente MD PA, at 9325 Glades Rd, Boca Raton, FL 33434-3988. The practice phone is (561) 483-6772.

Dr. Laracuente's primary practice is Ronald Laracuente MD PA in Boca Raton, Florida. Dr. Laracuente is also affiliated with Boca Raton Regional Hospital. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Laracuente to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laracuente practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Laracuente's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Laracuente's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, anxiety, bronchitis, chronic anemia and chronic diabetes among the conditions Dr. Laracuente treats.

CMS data shows 1,343 Medicare services from Dr. Laracuente across 9 procedure codes in 2024, for 245 Medicare patients. Medicare paid $92,820 for them. Every service was in an office.

CMS counts 245 Medicare patients who saw Dr. Laracuente in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Laracuente's median patient age at 58, with 54% women.

In 2024, Dr. Laracuente wrote 4,388 Medicare Part D claims for 390 patients. 88% of them were for generic drugs. CMS names the drug for 3,907 of them, across 84 drugs with 11 or more claims each, at $369,829 in total drug cost. In 2023, CMS named 4,369 claims across 89 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Laracuente for performance year 2024, reported individually. Dr. Laracuente accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Laracuente as offering telehealth.

Dmand AI links 1 paper to Dr. Laracuente in 2023. Dr. Laracuente's most frequent co-authors are Matthew Richard Carey, MBA, MD, Kevin Clerkin, MD and Paolo Carlo Colombo, MD.

CMS Open Payments shows 1,187 general payments to Dr. Laracuente from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,524.

Dr. Laracuente graduated from Rutgers New Jersey Medical School in 1996.

Dr. Laracuente is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.